コメント (10)
トラックバックは利用できません。
Diflucan is excreted in human milk, requiring careful risk-benefit analysis during lactation.
Diflucan is used for secondary prophylaxis in HIV patients with prior fungal infections.
Diflucan resistance can emerge during long-term suppressive therapy.
Diflucan is a Schedule H/P drug in many countries, requiring a prescription.
Development of resistance during long-term suppressive therapy is a documented risk.
May significantly increase cyclosporine and tacrolimus levels, requiring close monitoring.
First-line for uncomplicated vulvovaginal candidiasis due to high efficacy and patient convenience.
Diflucan is available in both oral tablet/suspension and intravenous formulations.
Diflucan exhibits fungistatic, not fungicidal, activity against most susceptible yeasts.
Can cause taste distortion (dysgeusia) in some patients.
Diflucan is excreted in human milk, requiring careful risk-benefit analysis during lactation.
Diflucan is used for secondary prophylaxis in HIV patients with prior fungal infections.
Diflucan resistance can emerge during long-term suppressive therapy.
Diflucan is a Schedule H/P drug in many countries, requiring a prescription.
Development of resistance during long-term suppressive therapy is a documented risk.
May significantly increase cyclosporine and tacrolimus levels, requiring close monitoring.
First-line for uncomplicated vulvovaginal candidiasis due to high efficacy and patient convenience.
Diflucan is available in both oral tablet/suspension and intravenous formulations.
Diflucan exhibits fungistatic, not fungicidal, activity against most susceptible yeasts.
Can cause taste distortion (dysgeusia) in some patients.